04.01.26 -- Reprogramming The Tumor Microenvironment

Pilatus Biosciences CEO Raven Lin shares learnings from his company's early-stage oncology program.

Vaccine development has dramatically accelerated, with average timelines dropping 85%. Clinical trial trends show a surge in early-phase platform studies and a new focus on therapeutic cancer vaccines.

Drug development experts remain intent on pharma’s prospects, especially in China, which have overtaken the US in first-time new drugs and continues to nurture a robust pipeline.

As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

Discover how a platform-first approach to RTSM eliminates the cycle of one-off builds, offering sponsors stable workflows, reusable logic, and consistent quality across every clinical trial.

Are you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.